The clinical application of self-inactivating (SIN) retroviral vectors has been hampered by the lack of reliable and efficient vector production technologies. To enable production of SIN γ-retroviral ...
In this study, a T-lymphoblastoid and a B-lymphoblastoid cell line were tested for their ability to produce MLV particles. A suspension amphotropic packaging cell line that produces high-titre, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results